Advanced glycated end-products (AGE) during haemodialysis treatment: Discrepant results with different methodologies reflecting the heterogeneity of AGE compounds

Nephrology Dialysis Transplantation

Volumn 14, Issue 8, 1999, Pages 1968-1975

  Henle, Thomas ^a   Deppisch, Reinhold ^a   Beck, Werner ^a   Hergesell, Olaf ^a   Hänsch, Gertrud M ^a   Ritz, Eberhard ^b  

^a Gambro Renal Care R and D ^*

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Advanced glycation end products; Diabetes; Fluorescence; High flux haemodialysis; HPLC; Maillard products; Pentosidine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; PENTOSIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FLUORESCENCE SPECTROSCOPY; GEL PERMEATION CHROMATOGRAPHY; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MALE; METHODOLOGY; MOLECULAR WEIGHT; PRIORITY JOURNAL; UREMIA;

ADULT; AGED; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOFILTRATION; HUMANS; LYSINE; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NORLEUCINE; PYRROLES; RENAL DIALYSIS;

EID: 0032803735     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.8.1968     Document Type: Article

References (34)

1. Maillard LC. Action des acides aminés sur les sucres. Formation des mélanoides par voi méthodique. C R Acad Sci Ser 1912; 145: 66-68
2. Ledl F, Schleicher E. New aspects of the Maillard reaction in food and in the human body. Angew Chem Int Edn Engl 1990; 29: 565-594
3. Henle T, Deppisch R, Ritz E. The Maillard reaction - from food chemistry to uraemia research. Nephrol Dial Transplant 1996; 11: 1718-1722
4. Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C. Oxidation conspires with glycation to generate noxious advanced glycation products in renal failure. Nephrol Dial Transplant 1997; 12: 255-258
5. Miyata T, Wada Y, Cai Z et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997; 51: 1170-1181
6. Miyata T, Fu MX, Kurokawa K., van Ypersele de Strihou C, Thorpe SR, Baynes JW. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int 1998; 54: 1290-1295
7. Koshinsky T, He CJ, Mitsuhashi T et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 1997; 94: 6474-6479
8. Odetti P, Cosso L, Pronzato MA, Dapino D, Guerri G. Plasma advanced glycosylation end-products in maintenance haemodialysis patients. Nephrol Dial Transplant 1995; 10: 2110-2113
9. Papanastasiou P, Grass L, Rodela H, Patrikarea A, Oreopoulos D, Diamandis EP. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int 1994; 46: 216-222
10. Friedlander MA, Wu YC, Schulak JA, Monnier VM, Hricik DE. Influence of dialysis modality on plasma and tissue concentration of pentosidine in patients with end-stage renal disease. Am J Kidney Dis 1995: 25: 445-451
11. Friedlander MA, Witko-Sarsat V, Nguyen AT et al. The advanced glycation endproduct pentosidine and monocyte activation in uremia. Clin Nephrol 1996; 45: 379-382
12. Makita Z, Bucala R, Rayfield EJ et al. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 1994; 343: 1519-1522
13. Dolhofer-Bliesener R, Lechner B, Deppisch R, Ritz E, Gerbitz KD. Immunological determination of advanced glycation end-products in human blood and urine. Nephrol Dial Transplant 1995; 10: 657-664
14. Miyata T, Ueda Y, Yoshida A et al. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int 1997; 51: 880-887
15. Henle T, Walter H, Krause I, Klostermeyer H. Efficient determination of individual Maillard compounds in heat-treated milk products by amino acid analysis. Int Dairy J 1991; 1: 125-135
16. Henle T, Schwarzenbolz U, Klostermeyer H. Detection and quantification of pentosidine in foods. Z Lebensm Unters Forsch 1997; 204: 95-98
17. Finot PA, Deutsch R, Bujard E. The extent of the Maillard reaction during the processing of milk. Prog Food Nutr Sci 1981; 5: 345-355
18. Henle T, Walter AW, Klostermeyer H. Simultaneous determination of protein-bound Maillard products by ion-exchange chromatography and photodiode array detection. In: Labuza TP, Reineccius GA, Monnier VM, O'Brien J, Baynes JW, eds, Maillard Reaction in Chemistry, Food and Health. The Royal Society of Chemistry, London: 1994; 195-200
19. Henle T, Schwarzenbolz U, Walter AW, Klostermeyer H. Protein-bound Maillard compounds in foods: analytical and technological aspects. In: O'Brien J, Nursten HE, Crabbe MJC, Ames JM, eds, The Maillard Reaction in Foods and Medicine. The Royal Society of Chemistry, London: 1998; 178-183
20. Henle T, Bachmann A. Synthesis of pyrraline. Z Lebensm Unters Forsch 1996; 202: 72-75
21. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1313
22. Thornalley JP. Advanced glycation and the development of diabetic complications. Unifying the involvement of glucose, methylglyoxal and oxidative stress. Endocrinol Metab 1996; 3: 149-166
23. Westwood ME, Thornalley JP. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J Protein Chem 1995; 14: 359-372
24. 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum. Kidney Int 1996; 49: 861-867
25. Goehl H, Buck R, Strathmann H. Basic features of the Polyamide membranes. Contrib Nephrol 1992; 96: 1-25
26. Ward RA, Schmidt B, Samtleben W. Alloying with a heat resistant polymer allows steam sterilisation and improves the performance of polyamide membranes. J Am Soc Nephrol 1998; 9: 186A
27. Schröder D, Riedel E, Beck W, Deppisch R, Pommer W. Elimination of dimethylarginines during hemodialysis (HD) and hemodiafiltration (HDF). J Am Soc Nephrol 1998; 9: 183A
28. Makita Z, Radoff S, Rayfield E et al. Advanced glycation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325: 836-842
29. Fishbane S, Bucala R, Pereira BJ, Founds H, Vlassara H. Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia. Kidney Int 1997; 52: 1645-1650
30. Li YM, Tan AX, Vlassara H. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nature Med 1995; 1: 1057-1061
31. Mitsuhashi T, Li YM, Fishbane S, Vlassara H. Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix. J Clin Invest 1997; 100: 847-854
32. Vlassara H, Brownlee M, Cerami A. Agents for removing advanced glycation endproducts. European Patent EP 0259893B1
33. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 1989; 264: 21597-21602
34. Miyata T, Ueda Y, Horie K et al. Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int 1998; 53: 416-422